Last reviewed · How we verify

NCT04785079

Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow

Completed NA Last updated 27 July 2022
What this trial tests

NA trial testing Graston Instrument assisted Soft tissue Mobilization in Asymptomatic Condition in 35 participants. Completed in 1 March 2022.

Timeline
1 August 2020
Primary endpoint
1 March 2022
1 March 2022

Quick facts

Lead sponsorFlorida Gulf Coast University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment35
Start date1 August 2020
Primary completion1 March 2022
Estimated completion1 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida Gulf Coast University

Who can join

Adults 18 to 65, any sex, with Asymptomatic Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate the short term change in blood flow in the superficial human tissue layers after the application of 3 min Graston instrumented assisted soft tissue mobilization on the plantar aspect of the foot and the trapezius muscle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asymptomatic Condition

Currently open trials in the same condition.

Other Florida Gulf Coast University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04785079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing